إعلان
إعلان
RKDA
Arcadia Biosciences, Inc.
2.63
USDبرعاية
+0.21
+8.92%
٠٨ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
2.65
+0.03
+1.14%
تقارير أرباح RKDA
النسبة الإيجابية المفاجئة
RKDA تفوق 22 من 38 آخر التقديرات.
58%
التقرير التالي
بيانات التقرير القادم
١٨ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$1.43M
/-$0.67
التغير الضمني من Q3 25 (Revenue/ EPS)
+9.68%
/-208.06%
التغير الضمني من Q4 24 (Revenue/ EPS)
+17.43%
/-77.59%
Arcadia Biosciences, Inc. earnings per share and revenue
On ٠٧ نوفمبر ٢٠٢٥, RKDA reported earnings of 0.62 USD per share (EPS) for Q3 25, beating the estimate of -0.55 USD, resulting in a 212.56% surprise. Revenue reached 1.30 مليون, compared to an expected 1.94 مليون, with a -32.82% difference. The market reacted with a -2.17% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 المحللين forecast an EPS of -0.67 USD, with revenue projected to reach 1.43 مليون USD, implying an نقصان of -208.06% EPS, and زيادة of 9.68% in Revenue from the last quarter.
الأسئلة الشائعة
What were Arcadia Biosciences, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Arcadia Biosciences, Inc. reported EPS of $0.62, beating estimates by 212.56%, and revenue of $1.30M, -32.82% below expectations.
How did the market react to Arcadia Biosciences, Inc.'s Q3 2025 earnings?
The stock price moved down -2.17%, changed from $3.69 before the earnings release to $3.61 the day after.
When is Arcadia Biosciences, Inc. expected to report next?
The next earning report is scheduled for ١٨ مارس ٢٠٢٦.
What are the forecasts for Arcadia Biosciences, Inc.'s next earnings report?
Based on 3
المحللين, Arcadia Biosciences, Inc. is expected to report EPS of -$0.67 and revenue of $1.43M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان